Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.
about
Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.Scaffold Hopping Toward Agomelatine: Novel 3, 4-Dihydroisoquinoline Compounds as Potential Antidepressant Agents.No effect of social group composition or size on hippocampal formation morphology and neurogenesis in mountain chickadees (Poecile gambeli).Experimental medication treatment approaches for depression.Antidepressant effects of resveratrol in an animal model of depressionThe roles of BDNF, pCREB and Wnt3a in the latent period preceding activation of progenitor cell mitosis in the adult dentate gyrus by fluoxetineDysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats.Could agomelatine be the ideal antidepressant?Retroinverso analogs of spadin display increased antidepressant effectsIntravenous injection of neural progenitor cells improved depression-like behavior after cerebral ischemia.Supplemental dietary choline during development exerts antidepressant-like effects in adult female rats.Neuroprotective Role of Intermittent Hypobaric Hypoxia in Unpredictable Chronic Mild Stress Induced Depression in Rats.Is it safe to use antidepressants after a stroke?Innovative approaches for the development of antidepressant drugs: current and future strategiesProspects for the treatment of depression.VEGF as a potential target for therapeutic intervention in depression.Emerging treatments for major depression.Regeneration and plasticity in the brain and spinal cord.The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building?Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampusLearning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants.Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder.A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients.Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.Management of patients with stroke: is it time to expand treatment options?Brain galanin system genes interact with life stresses in depression-related phenotypes.The complex role of the serotonin transporter in adult neurogenesis and neuroplasticity. A critical review.Developmental neuroplasticity and the origin of neurodegenerative diseases.Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication.New design strategies for antidepressant drugs.Effects of [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress.Advances in antidepressants for treating post-stroke depression.Antidepressant-like behavioral, anatomical, and biochemical effects of petroleum ether extract from maca (Lepidium meyenii) in mice exposed to chronic unpredictable mild stress.Shortened Spadin Analogs Display Better TREK-1 Inhibition, In Vivo Stability and Antidepressant Activity.Agomelatine and its therapeutic potential in the depressed patient.Increase in neurogenesis and behavioural benefit after chronic fluoxetine treatment in Wistar rats.Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression.Effects of the anti-multiple sclerosis immunomodulator laquinimod on anxiety and depression in rodent behavioral models.Biological activities of Zn(II)-S-methyl-cysteine complex as antiradical, inhibitor of acid phosphatase enzyme and in vivo antidepressant effects.Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.
P2860
Q27324635-9DAB08E0-E47A-4A59-9FC1-B54146A0ED9AQ28822571-BCCAF149-BD17-4646-8EAA-1288B535C241Q30475268-BFF2D7B6-8DBD-4846-AA58-635FFF759DF9Q33635577-475DF678-3F07-4095-B78C-AEC6F19BFE5CQ33663230-412BFBAA-F04E-440A-8B1E-550135B34AF7Q33737555-BF5A46DF-899D-4163-B387-02E61CBC05B2Q34273681-E261C484-C4F8-4B94-9CF5-B4BB45880795Q34572999-F0E211A8-F4CD-4762-81F8-61893FD7B725Q34996777-3D5D2078-C7CE-4EE1-B868-819CF29565EDQ35844177-0E62ECEB-6E89-4F48-8E9F-CEF4310E51CEQ35891361-35F4FC5C-135F-4660-B2BF-20696D17AA6CQ35930976-53B5F377-F08A-4A85-9CF1-2EA69F692235Q36235515-CCF92837-4654-41B6-AF04-69A7BCB70053Q36401400-35AB60B4-A5F2-4200-B8E2-1B7B54400E24Q36472992-CC9D68CC-6AC3-4F73-990C-D183E02A701AQ36484900-32FD2F0B-8B83-49C2-AA5F-08A7991FE706Q36730674-984D0909-D3DB-4BE6-80C0-FB363B92A7FCQ36773450-8C079C70-9290-4474-A394-BF1377472362Q36972430-6D45B518-4AA4-4DCA-A8AA-FB62B28879D4Q37118396-DD165F45-9601-4907-884B-5D89F9CFD446Q37189718-31046A2A-BA7C-4950-9C9C-71DC5BC1AFD0Q37231121-B40607FE-D1A9-404D-96C5-642043B91A72Q37271255-80739ABF-B666-45BE-BB6F-F9508AA3778AQ37405307-9450B284-ED7A-4B8E-9529-3DB7E01F5E79Q37656572-3F3F363B-D0B7-4DF4-B87B-F7A4C1466BF3Q37725359-82091D7F-FB85-48AE-83F5-EEAA748FE986Q37992701-1B8928E7-3FCF-4305-9021-9C319EE02E1EQ38109214-4E1045BB-F955-4BD9-9CFC-600FB28CEC4BQ38122158-FBC1288C-633C-43D8-A9B6-9CCDEA453458Q38132807-C4325162-D122-4CEC-AA4C-8116A90AD06CQ38833155-FA787D23-8DB7-422C-8DD6-206CE9D4C227Q39324538-E1258A96-32C2-470D-B233-D1865AF134FDQ39729826-8AA05074-B0E5-4C06-8BFD-2BA398241C4DQ41684438-7135F8AF-2B28-4791-9FD8-45D87C7C044DQ41866870-A83B2B10-CCC0-4C57-8A7B-E33EF4949D92Q46816109-109C3835-C4DA-4F58-AC38-008ECFF27E3BQ46947450-854A0825-0FEC-4B0F-BE7C-C069EA628A10Q47746037-9DD30FBF-BA7B-4E66-B665-B951AA54710AQ48059690-351BA163-C6B2-415E-A28E-024B3AD30F33Q48234108-3B9C0B21-CFF0-4283-8B1F-AC4AA5AB3BC1
P2860
Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.
@ast
Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.
@en
type
label
Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.
@ast
Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.
@en
prefLabel
Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.
@ast
Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.
@en
P356
P1476
Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs.
@en
P2093
Jessica E Malberg
Lee E Schechter
P304
P356
10.2174/1381612053382223
P577
2005-01-01T00:00:00Z